B

BiohacksAI

Evidence-Based Biohacking

Patent Pending

ATAD5

MOLECULAR TARGET

ATPase family AAA domain containing 5

UniProt: Q96QE3NCBI Gene: 7991571 compounds

ATAD5 (ATPase family AAA domain containing 5) is targeted by 71 compounds in the BiohacksAI evidence corpus, derived from PubMed bioassay data. Each compound is ranked by confidence score (log-normalized assay count × evidence quality).

Compounds Targeting ATAD5

Ranked by bioassay confidence score (PubChem active assay count × evidence quality).

#CompoundConfidenceActive Assays
1Genistein2.208
2Resveratrol2.208
3Colchicine2.087
4Disulfiram2.087
5streptonigrin2.087
6Anisomycin1.795
7Azacitidine1.795
8Azacitidine1.795
9Leflunomide1.795
10tyrphostin ag 14781.795
11Apigenin 5,7,4'-trihydroxy-flavone,1.614
12Bortezomib1.614
13Nocodazole Nocodazole is1.614
14vinblastine sulfate1.614
15Vorinostat1.614
16Pueraria1.393
1719-((1'S,4'R)-4'-hydroxy-1'-methoxy-2'-oxopentyl)geldanamycin [Supplementary Concept]1.393
18o-Phthalaldehyde1.393
19Thiabendazole 2-Substituted benzimidazole first introduced in 1962. It is active against1.393
20amlexanox1.102
21Axitinib1.102
22Calcimycin1.102
23Daunorubicin1.102
24Demecolcine1.102
25Digoxin1.102
26dilazep1.102
27Dinitrochlorobenzene1.102
28Febuxostat1.102
29Glutaral1.102
30Idarubicin1.102
31Ouabain1.102
32piceatannol1.102
33Podophyllotoxin1.102
34Reserpine1.102
35Riluzole1.102
36trichostatic acid [Supplementary Concept] related to trichostatin1.102
37tyrphostin ag 12951.102
38Vincristine1.102
39Methylene Blue0.691
40Quercetin0.691
41Tannins Polyphenolic compounds with molecular weights of around 500-3000 daltons and containing enough hydroxyl groups (1-2 per 100 MW) for effective cross linking of other compounds (ASTRINGENTS).0.691
422-Acetylaminofluorene0.691
43Azathioprine0.691
44calycosin0.691
45Camptothecin0.691
46Carboxin0.691
47Ciclopirox0.691
48cycloheximide0.691
49daph0.691
50Desonide0.691

Showing top 50 of 71 compounds. Use the BiohacksAI search to explore all ATAD5 modulators.

About ATAD5 as a Drug Target

ATAD5 (ATPase family AAA domain containing 5) is a well-characterized molecular target in biomedical research. BiohacksAI tracks 71 compounds with documented ATAD5 interaction from PubChem bioassay data, cross-referenced with PubMed clinical evidence. The confidence score reflects the log-normalized count of active PubChem assays, weighted by evidence quality from the BiohacksAI corpus.

ATAD5 inhibitors, activators, and modulators are of interest in research areas including longevity, metabolic health, and neurological function. Each compound profile includes evidence score, RCT count, human study ratio, research velocity, and domain relevance.